Skip to main content

Advertisement

SpringerLink
Log in

Nontuberculous mycobacteria infection in solid organ transplant recipients

  • Review
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

Although advances in surgical technique, drug-induced immunosuppression, and supportive medical therapy have led to improved survival and quality of live after solid organ transplantations, infections still represent a major threat for transplant recipients.

Infections with non tuberculous mycobacteria (NTM) are infrequent, but can be associated with relevant morbidity and mortality. With the exception of few comprehensive studies, the available literature consists predominantly of case reports and institutional experiences. This article reviews NTM infection in the setting of solid organ transplant (SOT) recipients dealing with clinical features, diagnosis, treatment and outcome. Published studies have documented a protean presentation of NTM infection in SOT recipients which may include skin and soft tissue lesions, osteoarticular infections and pleuropulmonary disease. An aggressive approach including histopathologic examination and acid-fast bacilli culture of aspirates or biopsy specimens from involved sites are essential for diagnosis. A combined treatment of debridement surgery, reduction of immunosuppressive medications and/or antimycobacterial drugs is frequently associated with a favorable outcome. It is strongly emphasized that a high index of suspicion for NTM infection should be maintained when managing SOT recipients with unusual clinical manifestations. Early diagnosis and initiation of therapy are essential to prevent morbidity and mortality in this vulnerable population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Alangaden GJ, Chandrasekar P, Samuel R, Bettiker RL, Truant AL, Jungkind D et al (2008) Cumitech 45: Infections in solid organ transplant recipients. Truant AL (ed) American Society for Microbiology, Washington D.C.

  2. Rubin RH (2002) The direct and indirect effects of infection in liver transplantation: pathogenesis, impact and clinical management. Curr Clin Top Infect Dis 22:125–154

    PubMed  Google Scholar 

  3. Snydman DR (1999) Infections in solid organ transplantation. Transpl Infect Dis 1:21–28

    Article  PubMed  CAS  Google Scholar 

  4. Wolinsky E (1979) Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 119:107–159

    PubMed  CAS  Google Scholar 

  5. Falkinham JO (1996) Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev 9:177–215

    PubMed  Google Scholar 

  6. Tortoli E (2003) Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s. Clin Microbiol Rev 16:319–354

    Article  PubMed  CAS  Google Scholar 

  7. Wood GL, Washington JA II (1987) Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects. Rev Infect Dis 9:275–294

    Article  Google Scholar 

  8. Herdman AV, Steele JCH (2004) The new mycobacterial species. Emerging or newly distinguished pathogens. Clin Lab Med 24:651–690

    Article  PubMed  Google Scholar 

  9. Doucette K, Fishman JA (2004) Nontuberculous mycobacterial infection in hemopoietic stem cell and solid organ transplant recipients. Clin Infect Dis 38:1428–1439

    Article  PubMed  Google Scholar 

  10. Marras TK, Chedore P, Ying AM, Jamieson F (2007) Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997–2003. Thorax 62:661–666

    Article  PubMed  Google Scholar 

  11. Khan K, Wang J, Marras TK (2007) Nontuberculous mycobacteria sensitization in the United States: national trends over three decades. Am J Crit Care Med 176:306–313

    Article  Google Scholar 

  12. Daley C (2009) Nontuberculous mycobacterial disease in transplant recipients: early diagnosis and treatment. Curr Opin Org Transpl 4:619–624

    Article  Google Scholar 

  13. Escalante P (2007) Mycobacterial infections in solid organ transplantation. Curr Opin Organ Trasplant 12:585–590

    Article  Google Scholar 

  14. Garrison AP, Morris ML, Doblecki LS, Smith L, Cleary TJ et al (2009) Mycobacterium abscessus infection in solid organ transplant recipients: report of three cases and review of the literature. Transpl Infect Dis 11:541–548

    Article  PubMed  CAS  Google Scholar 

  15. Dorman S (2004) Nontuberculous mycobacteria. Am J Transplant 4(suppl 10):42–46

    Google Scholar 

  16. American Thoracic Society (2007) Diagnosis, treatment, and prevention of nontuberculous mycobacterial disease. Am J Respir Crit Care Med 175:367–416

    Google Scholar 

  17. Field SK, Cowie RL (2006) Lung disease due the more common nontuberculous mycobacteria. Chest 129:1653–1672

    Article  PubMed  Google Scholar 

  18. Chalemskurlat W, Sood N, Neuringer IP, Hecker TM, Chang L, Rivera MP et al (2006) Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation. Thorax 61:507–513

    Article  Google Scholar 

  19. Haas S, Scully B, Cohen J (2005) Mycobacterium avium complex infection in kidney transplant patients. Transpl Infect Dis 7:75–79

    Article  PubMed  CAS  Google Scholar 

  20. Malouf MA, Glanville AR (1999) The spectrum of mycobacterial infections after lung transplantation. Am J Crit Care Med 160:1611–1616

    CAS  Google Scholar 

  21. Patel R, Paya CV (1997) Infections in solid-organ transplant recipients. Clin Microbiol Rev 10:86–124

    PubMed  CAS  Google Scholar 

  22. Young JH, Weisdorf DJ (2010) Typical and atypical Mycobacterium infections after hematopoietic stem cell or solid organ transplantation. In: Bowden RA, Ljungman P, Snydman DR (eds) Transplant infections, 3rd edn. Lippincott, Williams & Wilkins, Philadelphia, pp 282–294

  23. Patel R, Roberts GD, Keating MR, Paya CV (1994) Infections due to nontuberculous mycobacteria in kidney, heart, and liver transplant recipients. Clin Infect Dis 19:263–273

    Article  PubMed  CAS  Google Scholar 

  24. Dorman S, Subramanian A (2009) Nontuberculous mycobacteria in solid organ transplant recipients. Am J Transplant 9(suppl 4):S63–S69

    Article  PubMed  Google Scholar 

  25. Fan MH, Hadjiliadis D (2009) Incidence and management of mycobacterial infections in solid organ transplant recipients. Curr Infect Dis Rep 11:216–222

    Article  PubMed  Google Scholar 

  26. Martìn-Penagos M, Rodrigo E, Ruiz JC, Agüero J, Fernandez-Mazarrasa C et al (2009) Lung cavitation due to Mycobacterium xenopi in a renal transplant recipient. Transpl Infect Dis 11:249–252

    Article  PubMed  Google Scholar 

  27. Thaunat O, Morelon E, Stern M, Buffet P, Offredo C, Mamzer-Bruneel MF, Kreis H (2004) Mycobacterium xenopi pulmonary infection in two renal transplant recipients under sirolimus therapy. Transpl Infect Dis 6:179–182

    Article  PubMed  CAS  Google Scholar 

  28. Muñoz RM, Pulpòn LA, Yebra M, Segovia J, Gallego JC, Daz RM (2000) Intestinal involvement by nontuberculous mycobacteria after heart transplantation. Clin Infect Dis 30:603–605

    Article  PubMed  Google Scholar 

  29. Todd JL, Lakey J, Howell D, Reidy M, Zaas D (2007) Portal hypertension and granulomatous liver disease in a lung transplant recipient due to disseminated atypical mycobacterial infection. Am J Transpl 7:1300–1303

    Article  CAS  Google Scholar 

  30. Saubolle MA, Kiehn TE, White MH et al (1996) Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans. Clin Microbiol Rev 9:435–447

    PubMed  CAS  Google Scholar 

  31. Nurmohamed S, Weenink A, Moenilaram H, Visser C, Bemelman F (2007) Hyperammonemia in generalized Mycobacterium genavense infection after renal transplantation. Am J Transpl 7:722–723

    Article  CAS  Google Scholar 

  32. Doggett JS, Strasfeld L (2011) Disseminated Mycobacterium genavense with pulmonary nodules in a kidney transplant recipient: case report and review of the literature. Transpl Infect Dis 13:38–43

    Article  PubMed  CAS  Google Scholar 

  33. Piersimoni C, Scarparo C (2008) Pulmonary infections associated with non-tuberculous mycobacteria in immunocompetent patients. Lancet Infect Dis 8:323–334

    Article  PubMed  Google Scholar 

  34. Torre-Cisneiros J, De La Mata M, Rufian S, Villanueva Marcos JL, Aroca JG et al (1995) Importance of surveillance mycobacterial cultures after liver transplantation. Transplantation 60:1054–1055

    Google Scholar 

  35. Cernoch PL, Enns RK, Saubolle MA, Wallace RJ Jr (1994) Cumitechs 16A: laboratory diagnosis of the mycobacterioses. Weissfeld AS (ed) American Society for Microbiology, Washington D.C.

  36. Thomsen VØ, Dragsted UB, Bauer J, Fuursted K, Lundgren J (1999) Disseminated infection with Mycobacterium genavense: a challenge to physicians and mycobacteriologists. J Clin Microbiol 37:3901–3905

    PubMed  CAS  Google Scholar 

  37. Realini L, van der Stuyft P, De Ridder K, Hirschel B, Portaels F (1997) Inhibitory effects of polyoxyethylene stearate, PANTA and neutral pH on growth of Mycobacterium genavense in BACTEC primary cultures. J Clin Microbiol 35:2791–2794

    PubMed  CAS  Google Scholar 

  38. CLSI (2007) Laboratory detection and identification of mycobacteria; proposed guideline. M48-P. Clinical and Laboratory Standards Institute, Wayne, PA

  39. Wallace RJ Jr, Tanner D, Brannan PJ, Brown BA (1993) Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann Intern Med 119:482–486

    PubMed  Google Scholar 

  40. Wallace RJ Jr, Griffith DE, Oliver KN, Cook JL, Gordin F (1997) Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Crit Care Med 156:S1–S25

    Google Scholar 

  41. CLSI (2011) Susceptibility testing of mycobacteria, nocardia and other aerobic actinomycetes. Approved standard, 2nd edn, CLSI document M24-A2. Clinical and Laboratory Standards Institute, Wayne, PA

  42. Iseman MD, Fischer A (2008) Tumor necrosis factor-α at the intersection of mycobacterial immunity and pathogenesis: an important new address in medicine. Clin Infect Dis 46:1738–1740

    Article  Google Scholar 

  43. Wallis RS (2008) Mycobacterial disease attributable to tumor necrosis factor-α blockers. Clin Infect Dis 47:1603–1605

    Article  PubMed  Google Scholar 

  44. Van Ingen J, Boerce MJ, Dekhuijzen R, van Soolingen D (2008) Mycobacterial disease in patients with rheumatic disease. Nat Clin Pract Rheumathol 4:649–656

    Article  Google Scholar 

  45. Kesten S, Chaparro C (1999) Mycobacterial infections in lung transplant recipients. Chest 115:741–745

    Article  PubMed  CAS  Google Scholar 

  46. Finch CK, Chrisman CR, Baciewicz AM, Self TH (2002) Rifampin and rifabutin drug interaction: an update. Arch Intern Med 162:958–992

    Article  Google Scholar 

  47. Ferrari SL, Goffin E, Moraud M, Wallemacq P, Squiffiet JP, Pirsom Y (1994) The interaction between clarithromycin and cyclosporine in kidney transplant recipients. Transplantation 58:725–727

    PubMed  CAS  Google Scholar 

  48. Piemmons RM, McAllister CL, Garces MC, Ward RL (1997) Osteomyelitis due to Mycobacterium haemophilum in a cardiac transplant patient. Case report and analysis of interactions among clarithromycin, rifampin and cyclosporine. Clin Infect Dis 24:995–997

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Regional Reference Mycobacteria Laboratory, United Hospitals, via Conca 71, 60020, Ancona, Italy

    C. Piersimoni

Authors
  1. C. Piersimoni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Piersimoni.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Piersimoni, C. Nontuberculous mycobacteria infection in solid organ transplant recipients. Eur J Clin Microbiol Infect Dis 31, 397–403 (2012). https://doi.org/10.1007/s10096-011-1329-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-011-1329-4

Keywords

Search

Navigation